Predicting heart failure following myocardial infarction by protease and protease inhibitor profiling
US8445222B2 · kind B2 · utility
1Cited by
10References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 11, 2007 |
| Grant date | May 21, 2013 |
| Priority date | — |
| Expiry date | Jul 4, 2029 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/325
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Disclosed herein are methods of detecting or predicting diastolic heart failure in a subject, comprising identifying a profile of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) from a body fluid of the subject that is associated herein with the existence of likely development of left ventricular dilation (LVD).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.